Modified western blot with recombinant antigens for serological differentiation between HTLV-I and HTLV-II. 1994

M Chironna, and M Quarto, and C Germinario, and A Fontana
Institute of Hygiene-University of Bari, Policlinico, Italy.

Some epidemiological and clinical features of HTLV-I and HTLV-II infections remain unclear due to the inability to confirm and distinguish between the two retroviruses. Since HTLV-I and HTLV-II have a high degree of genomic and aminoacid sequence homology, serologic crossreactions are frequent, making it difficult to establish an accurate serologic diagnosis. To confirm and differentiate HTLV-I/II infections, different serologic confirmatory assays were compared. Fourteen serum samples from 11 IVDU, a bisexual subject, a polytransfused and an ATL patient were examined. The sera repeatedly reactive by Elisa and indeterminate with a conventional Western Blot with viral lysate, were retested by new modified Western Blots containing recombinant antigens. All sera from IVDU but one were confirmed and typed as HTLV-II while serum from ATL was serologically typed as HTLV-I. Serum from the polytransfused patient was not confirmed while serum from the bisexual remained indeterminate. These findings suggest that recombinant antigens are useful for serological diagnosis of HTLV-I/II infections.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015480 Deltaretrovirus Antibodies Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens. BLV Antibodies,HTLV Antibodies,HTLV-BLV Antibodies,Human T-Cell Leukemia Virus Antibodies,Leukemia Virus Antibodies, Human T-Cell,Leukemia-Lymphoma Virus Antibodies, Human T-Cell,T-Cell Leukemia-Lymphoma Virus Antibodies, Human,Human T Cell Leukemia Virus Antibodies,Leukemia Lymphoma Virus Antibodies, Human T Cell,Leukemia Virus Antibodies, Human T Cell,T Cell Leukemia Lymphoma Virus Antibodies, Human,Antibodies, BLV,Antibodies, Deltaretrovirus,Antibodies, HTLV,Antibodies, HTLV-BLV,HTLV BLV Antibodies
D015485 Deltaretrovirus Antigens Antigens associated with the DELTARETROVIRUS; HTLV-I ANTIGENS and HTLV-II ANTIGENS belong to this group. BLV Antigens,HTLV Antigens,HTLV-BLV Antigens,Human T-Cell Leukemia Virus Antigens,Leukemia Virus Antigens, Human T-Cell,Leukemia-Lymphoma Virus Antigens, Human T-Cell,T-Cell Leukemia-Lymphoma Virus Antigens, Human,Human T Cell Leukemia Virus Antigens,Leukemia Lymphoma Virus Antigens, Human T Cell,Leukemia Virus Antigens, Human T Cell,T Cell Leukemia Lymphoma Virus Antigens, Human,Antigens, BLV,Antigens, Deltaretrovirus,Antigens, HTLV,Antigens, HTLV-BLV,HTLV BLV Antigens
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015491 HTLV-II Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2. Human T-lymphotropic Virus 2 Infection,Human T-lymphotropic Virus 2 Infections,Infections, HTLV-II,HTLV-II Infection,Human T lymphotropic Virus 2 Infection,Human T lymphotropic Virus 2 Infections,Infection, HTLV-II,Infections, HTLV II

Related Publications

M Chironna, and M Quarto, and C Germinario, and A Fontana
June 1990, Lancet (London, England),
M Chironna, and M Quarto, and C Germinario, and A Fontana
August 1991, Lancet (London, England),
M Chironna, and M Quarto, and C Germinario, and A Fontana
November 1990, Lancet (London, England),
M Chironna, and M Quarto, and C Germinario, and A Fontana
August 1995, Clinical and diagnostic virology,
M Chironna, and M Quarto, and C Germinario, and A Fontana
September 1991, International journal of cancer,
M Chironna, and M Quarto, and C Germinario, and A Fontana
August 2011, Viruses,
M Chironna, and M Quarto, and C Germinario, and A Fontana
June 2003, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
M Chironna, and M Quarto, and C Germinario, and A Fontana
January 1991, Bulletin of the World Health Organization,
M Chironna, and M Quarto, and C Germinario, and A Fontana
August 1991, The Journal of infectious diseases,
Copied contents to your clipboard!